Madrigal Pharmaceuticals (MDGL) Accounts Payables (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Accounts Payables of $60.8 million for Q1 2026, up 44.57% year-over-year from $42.1 million in Q1 2025, and up 24.39% on a QoQ basis from $48.9 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) has 17 years of Accounts Payables data on file, last reported at $60.8 million in Q1 2026.
- Quarterly Accounts Payables rose 44.57% year-over-year to $60.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.8 million (up 44.57% YoY) and the FY2025 annual result came in at $48.9 million, up 12.11% from the prior year.
- Accounts Payables improved to $60.8 million in Q1 2026 per MDGL's latest filing, from $48.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $60.8 million in Q1 2026 and bottomed at $9.0 million in Q2 2024.
- The 5-year median for Accounts Payables is $23.8 million (2022), against an average of $29.7 million.
- The widest annual swing landed in 2022, when Accounts Payables soared 958.48%; it then sank 48.71% in 2024.
- Tracing MDGL's Accounts Payables over 5 years: stood at $23.8 million in 2022, then rose by 17.67% to $28.0 million in 2023, then surged by 55.48% to $43.6 million in 2024, then rose by 12.11% to $48.9 million in 2025, then advanced by 24.39% to $60.8 million in 2026.
- Per Business Quant, the three latest MDGL Accounts Payables figures stand at $60.8 million (Q1 2026), $48.9 million (Q4 2025), and $44.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - | 60.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.80 Mn |
| Dec 31, 2025 | 48.88 Mn |
| Sep 30, 2025 | 44.94 Mn |
| Jun 30, 2025 | 37.98 Mn |
| Mar 31, 2025 | 42.06 Mn |
| Dec 31, 2024 | 43.60 Mn |
| Sep 30, 2024 | 45.97 Mn |
| Jun 30, 2024 | 8.99 Mn |
| Mar 31, 2024 | 21.53 Mn |
| Dec 31, 2023 | 28.04 Mn |
| Sep 30, 2023 | 16.54 Mn |
| Jun 30, 2023 | 17.53 Mn |
| Mar 31, 2023 | 12.13 Mn |
| Dec 31, 2022 | 23.83 Mn |
| Sep 30, 2022 | 18.56 Mn |
| Jun 30, 2022 | 11.29 Mn |
| Mar 31, 2022 | 22.78 Mn |
| Dec 31, 2021 | 21.38 Mn |
| Sep 30, 2021 | 10.42 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 4.40 Mn |
| Dec 31, 2020 | 1.02 Mn |
| Sep 30, 2020 | 6.28 Mn |
| Jun 30, 2020 | 5.00 Mn |
| Mar 31, 2020 | 1.12 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 773,000.00 |
| Jun 30, 2019 | 446,000.00 |
| Mar 31, 2019 | 4.38 Mn |
| Dec 31, 2018 | 2.49 Mn |
| Sep 30, 2018 | 1.03 Mn |
| Jun 30, 2018 | 588,000.00 |
| Mar 31, 2018 | 1.42 Mn |
| Dec 31, 2017 | 1.93 Mn |
| Sep 30, 2017 | 1.40 Mn |
| Jun 30, 2017 | 1.29 Mn |
| Mar 31, 2017 | 2.78 Mn |
| Dec 31, 2016 | 762,000.00 |
| Sep 30, 2016 | 1.16 Mn |
| Jun 30, 2016 | 680,000.00 |
| Mar 31, 2016 | 744,000.00 |
| Dec 31, 2015 | 102,293.00 |
| Sep 30, 2015 | 1.42 Mn |
| Jun 30, 2015 | 3.02 Mn |
| Mar 31, 2015 | 3.74 Mn |
| Dec 31, 2014 | 3.14 Mn |
| Sep 30, 2014 | 4.44 Mn |
| Jun 30, 2014 | 5.23 Mn |
| Mar 31, 2014 | 5.81 Mn |
| Dec 31, 2013 | 6.59 Mn |
| Sep 30, 2013 | 5.69 Mn |
| Jun 30, 2013 | 5.22 Mn |
| Mar 31, 2013 | 5.72 Mn |
| Dec 31, 2012 | 5.66 Mn |
| Sep 30, 2012 | 3.69 Mn |
| Jun 30, 2012 | 3.47 Mn |
| Mar 31, 2012 | 3.04 Mn |
| Dec 31, 2011 | 3.47 Mn |
| Sep 30, 2011 | 2.92 Mn |
| Jun 30, 2011 | 2.00 Mn |
| Dec 31, 2010 | 1.93 Mn |